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Background: Stress or psychological distress is often described as a causative or maintaining factor in psoriasis.
Psychological traits may influence the appraisal, interpretation and coping ability regarding stressful situations.
Detailed investigations of psychological traits in relation to stress reactivity in psoriasis are rare. The aim of this
study was to examine whether patients with psoriasis who report an association between psychological distress
and exacerbation, “stress reactors” (SRs), differ psychologically from those with no stress reactivity “non-stress
reactors” (NSRs).
Methods: This cross-sectional study was conducted among 101 consecutively recruited outpatients with plaque
psoriasis. A psychosocial interview was performed including questions concerning stress reactivity in relation to
onset and exacerbation. Three validated self-rating scales were used: Spielberger State-Trait Anxiety Inventory (STAI,
Form-Y), Beck Depression Inventory (BDI-II) and Swedish Universities Scales of Personality (SSP). Independent samples
t-tests, Chi-square tests and one-way ANOVA analyses were used for group comparisons when appropriate. A logistic
regression model was designed with SR as the dependent variable.
Results: Sixty-four patients (63%) reported a subjective association between disease exacerbation and stress (SRs).
Patients defined as SRs reported significantly higher mean scores regarding state and trait anxiety, depression, and also
five SSP scale personality traits, i.e. somatic trait anxiety, psychic trait anxiety, stress susceptibility, lack of assertiveness
and mistrust, compared with NSRs. In multivariate analysis, SSP-stress susceptibility was the strongest explanatory
variable for SR, i.e. OR (95% CI) = 1.13 (1.02 – 1.24), p = 0.018.
Conclusion: According to our results, patients who perceive stress as a causal factor in their psoriasis might have a
more vulnerable psychological constitution. This finding suggests important opportunities for clinicians to identify
patients who may benefit from additional psychological exploration and support.
Keywords: Plaque psoriasis, Psychology, Stress, Anxiety, Depression, Personality assessmentBackground
Psoriasis is one of the most common immune-mediated
skin diseases and is known to have a systemic inflamma-
tory involvement [1]. The estimated prevalence of psoria-
sis is 1.5 – 3% in Scandinavia and Northern Europe [2,3].
A genetic–environmental interaction seems to offer a
plausible aetiological explanation of psoriasis [1], and
psychological distress has often been suggested as an
important trigger [4,5]. Only a few prospective studies
of stress and psoriasis exist [4,6,7], and the associations* Correspondence: charlotta.remrod@med.lu.se
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unless otherwise stated.and mechanisms involved remains unclear. Despite the
lack of strong aetiological evidence for the association
between psychological distress and psoriasis, between
37% and 71% of patients report psychological distress as
one of the major causative agents for onset, exacerba-
tion and maintenance of their psoriasis [8-15]. These
patients may be defined as stress reactors. Psychological
distress has also been found to reduce efficacy of treat-
ment in psoriasis [16], and improvement of clinical
parameters as a result of psychological interventions
adds further evidence for the association between psy-
chological distress and psoriasis [17,18].
Nevertheless, research has shown that focusing solely on
stressors from the environment is too simplistic [19,20].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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by all individuals with such exposure, because individual
responses are highly influenced by perceptions and in-
terpretation of events. Genetic, personal, emotional and
social factors will determine whether an individual can
tolerate and overcome the effects of stressors [19,20].
Consequently, psychological traits are of significant
importance in stress theory and research. Personality in-
fluences both the exposure to, and appraisal of stressful
situations, and also the individual’s interpretation of
stressors and coping ability [19]. Some psychological traits
can possibly predict increased emotional and physiological
reactivity under stressful conditions [19-22].
Although stress has been recognised as an important
factor within the field of psoriasis research, detailed in-
vestigations of psychological traits and clinical character-
istics in relation to perceived stress-reactivity are rare.
One of the few larger studies to elucidate this subject
was conducted by Zachariae et al., [8] who found an
association between subjective stress-reactivity and indi-
cators of psychological vulnerability. Some smaller stud-
ies have reported subjective stress-reactivity to be
associated with poorer levels of psychosocial well-being
[13], pathological worrying [7,23], difficulties with asser-
tion of anger, and dependency upon approval [9].
Devrimci-Ozguven et al. [14] showed conflicting results
with no association between stress-reactivity and psy-
chological morbidity. To the best of our knowledge, no
previous study has as yet used a larger structured per-
sonality inventory in an investigation of stress reactivity
in psoriasis.
The aim of this study was to examine the subjective
influence of stress on psoriasis onset and exacerbations.
Furthermore, we wanted to compare persons charac-
terised as “stress reactors” (SRs) and “non-stress reac-
tors” (NSRs) with respect to psychological variables,
clinical- and socio-demographic factors and psoriasis-
related distress. We hypothesise that stress-reactors have
a more psychologically vulnerable constitution, as com-
pared with non-stress reactors. By psychological vulner-
ability, we refer to an individual’s inability to withstand
the effects of a potentially stressful environment, due to




All subjects were recruited consecutively from planned
visits at the out-patient clinic of the Department of
Dermatology and Venereology at the Skåne University
Hospital in Malmö, Sweden. Inclusion criteria were:
plaque psoriasis diagnosed by dermatologist, men and
women aged 18 – 65 years, good command of the Swedish
language, and no serious mental or cognitive disturbances.A total of 109 patients were approached during early
autumn 2008 (53%) and autumn 2009 (47%). Of them,
102 agreed to participate (94%) and gave their oral and
written informed consent. One patient dropped out of
the study, due to personal considerations. All of the 101
(93%) remaining patients were unpaid volunteers. A
comparison of the two cohorts from 2008 and 2009
showed no statistically significant differences regarding
any socio-demographic and clinical variables. The sub-
jects were accordingly regarded as one cohort in statis-
tical analyses.
No statistically significant differences were found be-
tween men and women regarding socio-demographic
and clinical variables, psychosocial-, psychological-, and
psoriasis-related variables.Methods
A psychosocial semi-structured 25-item interview was
conducted in a quiet room at the out-patient clinic. All
subjects were interviewed by the same researcher (CR).
The interview was designed by two of the authors (KS
and CR), with the purpose of assessing (i) socio-
demographic variables, (ii) social situation and close
relationships, and (iii) psoriasis-related distress. An-
swers were rated on a 5-point Likert scale. Regarding
(ii) social situation and close relationships, patients
were asked about satisfaction with living conditions,
working conditions, private economy and satisfaction
with relationships with mother, father, partner, children,
friends and colleagues. Answers were dichotomised as
“satisfied” (1–3) and “not satisfied” (4–5). Regarding (iii)
psoriasis-related distress, patients were asked about
their psoriasis impact on daily life and on sexual rela-
tions. Answers were dichotomised as “low impact” (1–3)
and “high impact” (4–5).
At the end of the interview, patients were asked: (A)
“Do you relate the onset of your psoriasis to a particular
stressful life situation?” (Answers were given as “yes”,
“no”, “don’t know”), and (B) “Do you experience that your
psoriasis is aggravated during times of stress?” (Answers
were given as “yes”, “no”, “sometimes” or “don’t know”).
For question (B), two groups were created for group com-
parisons, i.e. “stress reactors” (SRs) = (yes) and “non-stress
reactors” (NSRs) = (no).
All patients were asked to rate their general degree of
pruritus on a Visual Analogue Scale (VAS). The scale
consisted of a 10 cm straight line without numbers or
sections. The left end was labelled “no pruritus”, and the
right end was labelled “severe pruritus”.
After the interview, each patient was given privacy to
complete three psychometric self-rating scales in a quiet
room, with the researcher readily available for questions
in a room nearby.
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The STAI (Form-Y) is a well-established self-rating scale
with high stability and validity, often used in clinical re-
search [24]. The first 20 statements assess state anxiety,
i.e. anxiety at a particular moment or at a chosen period
of time. (The subjects were asked to rate their state
anxiety during the last week). The subsequent 20 state-
ments assess trait anxiety, i.e. the relatively stable anxiety
proneness. Answers are given on a 4-point Likert scale,
and scores on the state and trait scales, respectively,
range from 20 to 80 points. In large normative samples
of working adults and college students, the mean values
of state and trait anxiety for men range from 35.7 to
36.5 and 34.9 to 38.3, respectively, and for women from
35.2 to 38.8 and 34.8 to 40.4, respectively [24].
Beck depression inventory (BDI-II)
The Beck Depression Inventory Second Edition (BDI-II)
is one of the most widely used self-report measures of
depression in both research and clinical practice, with
high validity and good psychometric properties [25]. The
questionnaire consists of 21 items, and answers are rated
on a four-point scale (0 = low, 3 = high). The total score
ranges from 0 to 63. For persons who have been clinic-
ally investigated for depression, scores from 0–13 repre-
sent minimal depressive symptoms, scores of 14–19
indicate mild, scores of 20–28 indicate moderate, and
scores of 29–63 indicate severe depressive symptoms
[25]. Question number 16 evaluates sleep disturbances.
Since sleep disturbances may be associated both with de-
pression and stress reactivity, this variable was extracted,
dichotomised and used in statistical analyses.
Swedish universities scales of personality (SSP)
The SSP is a thorough revision of the older Karolinska
Scales of Personality (KSP). In contrast to many other
personality inventories, SSP does not intend to measure
“the entire personality”, but has been developed to iden-
tify stable traits of psychological vulnerability and psy-
chopathology. Psychological vulnerability is believed to
predispose the individual to psychological problems [26].
The questionnaire comprises 91 items with a 4-point
Likert response scale. The items are sorted into 13 sub-
scales, each designed to measure one personality trait:
(1) Somatic Trait anxiety, (2) Psychic Trait Anxiety, (3)
Stress Susceptibility, (4) Lack of Assertiveness, (5) Im-
pulsiveness, (6) Adventure Seeking, ( 7) Detachment, (8)
Social Desirability, (9) Embitterment, (10) Trait Irritabil-
ity, (11) Mistrust, (12) Verbal Trait Aggression, and (13)
Physical Trait Aggression [27]. The SSP has been stan-
dardised in a large representative Swedish national sample,
and the internal consistency with regard to Cronbach’s
alpha coefficient ranged from 0.59 to 0.84 in a normative
sample [26]. The subscales are transformed into T scoresaccording to the SSP computer algorithm. T scores (mean
50, SD 10) are standardised with regard to age and sex on
the basis of a normal control group. Values of 10 points
above or below 50 in each SSP scale indicate a difference
from the standard population by 1.0 SD [27].
Psoriasis area and severity index (PASI)
Clinical assessment of PASI was conducted on 48 pa-
tients recruited during autumn 2009. The PASI scoring
system is currently the best evaluated and the most
widely used objective method to evaluate clinical severity
of psoriasis [28]. The PASI combines the assessment of
the area affected and the severity of lesions into a single
score ranging from 0 (no disease) to 72 (severe disease).
Severity has been categorised as follows: PASI < 7 =mild
plaque psoriasis, PASI 7–12 =moderate plaque psoriasis,
PASI > 12 = severe plaque psoriasis [29].
Statistical analysis
Independent samples t-tests, Chi-square tests and one-
way ANOVA analyses were used for group comparisons
when appropriate. Post hoc multiple comparisons were
performed, using Tukey’s test to identify pairwise signifi-
cant differences. A logistic regression model was designed
with SR as the dependent variable. All psychometric vari-
ables with a significant difference between SR and NSR in
group comparisons were included and analysed in the
model. The psychometric variables were first analysed sep-
arately, then adjusted for potential covariates, and finally
with all psychometric variables and covariates included in
the same model. Covariates used in the final model were
age, gender, psoriasis impact on daily life, and age at debut
of psoriasis. Age at debut was included since an associ-
ation between this variable and psychological vulnerability
has previously been found [30]. Other potential covariates
that did not reach significance in the first adjustment were
excluded from the final model, and they were: psycho-
social variables sleep disturbances, alcohol consumption,
PASI, pruritus and BMI. Two-tailed p-values < 0.05 were
considered to be statistically significant. Statistical analyses
were carried out using the Statistical Package for the
Social Sciences, version 21.0 (SPSS™, Chicago, IL, USA).
The Ethics Committee of the Medical Faculty, Univer-
sity of Lund approved the study.
Results
Socio-demographic and clinical characteristics of the
sample are given in Table 1.
Psychosocial interview
Most patients were satisfied with living conditions (93%),
working conditions (98% of n = 90), private economy
(89%) and also with relationships with mother (92% of
n = 99), father (86% of n = 94), partner (91% of n = 77),







Mean (SD), Mdn (range) 43.5 (13.8), 45 (18–65)
Age at onset of disease (years)
Mean (SD), Mdn (range) 24.7 (14.5), 20 (0–61)
Duration of disease (years)
Mean (SD), Mdn (range) 18.8 (12.7), 18 (1–56)
BMI
Mean (SD), Mdn (range) 26.2 (4.5), 26.3 (17.6-38.5)
PASI (n = 48)
Mean (SD), Mdn (range) 5.4 (4.3), 4.2 (0–21.7)
Mild psoriasis, n (%) 37 (77)
Moderate psoriasis, n (%) 8 (17)
Severe psoriasis, n (%) 3 (6)




Divorced or widow/widower 9 (9)
Educational level, n (%)
1-9 years 11 (11)
10-12 years 37 (37)
>12 years 53 (52)
Employment, n (%)
Full time 66 (65)
Part time 13 (13)
Unemployed / retired 22 (22)




Mean (SD), Mdn (range) 45.9 (59.8), 30 (0–360)
Risk consumption:a
Men, n (%) 3 (3)
Women, n (%) 2 (2)
BMI, Body Mass Index; PASI, Psoriasis Area and Severity Index.
aAlcohol risk consumption (standard drinks/week); men > 14, women > 9.
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colleagues (98% of n = 80). Forty-nine patients (48%) re-
ported that their psoriasis had a high impact on their
daily life, and 27 patients (27%) reported that their psor-
iasis had a high impact on sexual relations.Stress and exacerbation
Sixty-four patients (63%) were defined as “stress reac-
tors” (SRs), 26 patients (26%) “non- stress reactors”
(NSRs), seven patients (7%) answered “don’t know” and
four patients (4%) “sometimes”. Statistically significant
differences between SRs and NSRs were found regarding
mean scores of state, and trait anxiety, BDI-II and five
personality traits on the SSP scale, i.e. somatic trait
anxiety, psychic trait anxiety, stress susceptibility, lack of
assertiveness and mistrust. Results are presented in
Table 2 together with descriptive mean scores for the total
sample and all four groups of subjective stress-reactivity.
No statistically significant differences between SRs and
NSRs were found regarding all socio-demographic and
clinical variables shown in Table 1, psychosocial variables,
psoriasis-related distress or sleep disturbances.
In multivariate logistic regression analysis, the psycho-
metric variables tested were all significant explanatory
variables for SR when analysed as single variables. When
these analyses were controlled for potential covariates,
all psychometric variables remained significant, except
SSP-mistrust. When analysing all psychometric variables
with covariates in the same model, SSP-stress suscepti-
bility was the only significant explanatory variable for
SR. Due to multi-collinearity between the psychometric
variables, the other psychometric variables did not re-
main significant. Odds-ratios (95% CI) and p-values are
presented in Table 3.
SSP-stress susceptibility
Scores of SSP-stress susceptibility were positively corre-
lated with scores of state and trait anxiety (r = 0.61 and
r = 0.73 respectively, p < 0.0001), scores of BDI-II (r = 0.61,
p < 0.0001), SSP-somatic trait anxiety (r = 0.60, p < 0.0001),
SSP-psychic trait anxiety (r = 0.75, p < 0.0001), SSP-lack
of assertiveness (r = 0.47, p < 0.0001) and SSP-mistrust
(r = 0.50, p < 0.0001). No significant correlation or mean
differences were found between SSP-stress susceptibility
and of the socio-demographic and clinical variables shown
in Table 1, psychosocial variables or sleep disturbances.
Stress and onset of psoriasis
Fifty patients (49%) reported an experience of disease
onset during a stressful life situation. Thirty-seven
patients (37%) did not, and 14 patients (14%) answered
“don’t know”. Patients with onset related to stress had
significantly higher mean age at onset compared with
those who answered “no” (29.2 years vs 21.8 years, p =
0.040) and those who answered “don’t know” (15.9 years,
p = 0.005). Compared with those who answered “no”,
patients with onset related to stress had significantly
higher mean scores of state anxiety (40.1 vs. 34.1, p =
0.045), trait anxiety (38.9 vs. 32.2, p = 0.023), BDI-II
(10.0 vs. 5.8, p = 0.043) and SSP-psychic trait anxiety
Table 2 Results from the psychometric scales Mean scores from the total sample, for the different groups of subjective
stress reactivity and group comparisons of SRs vs. NSRs
Total “Yes” (SR) ”No” (NSR) “Don’t know” “Sometimes” SR vs. NSR
Significance
of difference, p
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
(N = 101) (n = 64) (n = 26) (n = 7) (n = 4)
STAI
State anxiety 38.0 (12.2) 40.5 (12.5) 29.9 (8.0) 44.0 (10.1) 40.8 (10.9) <0.0001
Trait anxiety 36.5 (11.9) 38.3 (12.1) 28.0 (6.4) 43.1 (13.3) 35.0 (12.0) <0.0001
BDI-II Depression 8.4 (8.1) 10.0 (8.5) 3.4 (3.6) 13.1 (10.4) 7.0 (4.1) <0.0001
SSP
Somatic Trait Anxiety 51.2 (10.8) 53.2 (10.4) 45.1 (9.8) 58.1 (10.8) 47.1 (4.9) 0.001
Psychic Trait Anxiety 47.5 (9.9) 49.2 (10.6) 42.1 (6.3) 53.3 (6.7) 46.6 (12.6) <0.0001
Stress Susceptibility 50.7 (10.9) 53.5 (10.9) 42.1 (7.7) 55.4 (7.1) 53.9 (7.8) <0.0001
Lack of Assertiveness 47.0 (9.9) 48.9 (10.6) 42.1 (6.1) 49.9 (10.8) 43.5 (4.5) <0.0001
Impulsiveness 50.8 (9.9) 51.3 (10.0) 50.0 (10.9) 52.3 (6.7) 46.6 (9.1) n.s.
Adventure seeking 49.7 (9.3) 49.5 (9.9) 49.5 (8.5) 51.6 (8.6) 52.4 (8.5) n.s.
Detachment 47.0 (10.2) 47.2 (10.3) 44.6 (9.6) 53.5 (7.7) 47.5 (15.7) n.s
Social Desirability 51.2 (9.7) 51.6 (10.5) 51.5 (9.9) 47.4 (7.6) 49.5 (5.4) n.s
Embitterment 50.6 (10.1) 51.9 (10.0) 47.7 (8.3) 51.9 (8.2) 45.3 (2.6) n.s.
Trait Irritability 49.3 (10.4) 49.9 (11.2) 46.3 (9.1) 55.0 (9.4) 48.7 (2.0) n.s.
Mistrust 48.9 (11.6) 49.8 (11.7) 43.7 (10.6) 59.1 (8.2) 50.3 (6.1) 0.024
Verbal Trait Aggression 49.5 (10.7) 48.9 (11.1) 50.3 (10.4) 53.5 (10.7) 48.2 (7.9) n.s.
Physical Trait Aggression 48.0 (10.2) 47.8 (9.6) 48.2 (11.0) 54.2 (12.7) 39.3 (5.9) n.s.
SR: stress reactors; NSR: non-stress reactors; STAI: State- and Trait anxiety Inventory; BDI-II: Beck Depression Inventory-II; SSP: Swedish Universities Scales of Personality.
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ferences between the three groups were found regarding
the other socio-demographic and clinical variables
shown in Table 1, other SSP-traits, psychosocial vari-
ables, psoriasis-related distress or sleep disturbances.
Discussion
In our study, more than half of the patients reported
stress as a causative agent for exacerbation of their psor-
iasis. Subjective stress reactivity (SR) was associated withTable 3 Results from the logistic regression analyses with “st




OR (95% CI) p OR (95% CI)
STAI Trait anxiety 1.14 (1.06 – 1.22) <0.0001 1.14 (1.06 – 1.
BDI-II Depression 1.20 (1.07 – 1.34) 0.001 1.22 (1.08 – 1.
SSP Somatic trait anxiety 1.08 (1.03 – 1.14) 0.002 1.08 (1.02 – 1.
Psychic trait anxiety 1.09 (1.03 – 1.16) 0.004 1.09 (1.02 – 1.
Stress susceptibility 1.14 (1.07 – 1.23) <0.0001 1.15 (1.07 – 1.
Lack of assertiveness 1.09 (1.03 – 1.15) 0.005 1.09 (1.02 – 1.
Mistrust 1.06 (1.01 – 1.11) 0.028 1.05 (0.99 – 1.
STAI: Spielberger State- and Trait anxiety Inventory, BDI-II: Beck Depression Inventor
aCovariates: age, gender, psoriasis impact on daily life, age at debut of psoriasis.both higher scores of depression, anxiety, and also five
personality traits on the SSP scale, i.e. stress-susceptibility,
somatic anxiety, psychic anxiety, lack of assertiveness
and mistrust. SSP-stress susceptibility showed the stron-
gest association with SR in multivariate regression analysis
and seems to be the most relevant personality trait in
this study.
Individuals with high scores of SSP-stress susceptibility
more often state that they “get tired and hurried too
easily”, “can not handle being interrupted when workingress reactor” as dependent variable (N =90)
single variables
esa
All psychometric variables with
covariatesa in the same model
p OR (95% CI) p
23) <0.0001 1.10 (0.97 – 1.24) 0.136
38) 0.002 1.11 (0.92 – 1.35) 0.269
14) 0.005 1.05 (0.96 – 1.14) 0.322
16) 0.007 0.85 (0.71 – 1.02) 0.083
24) <0.0001 1.13 (1.02 – 1.24) 0.018
16) 0.008 1.08 (0.98 – 1.19) 0.104
10) 0.061 0.98 (0.91 – 1.06) 0.657
y-II, SSP: Swedish Universities Scales of Personality.
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spend more energy than most others do”, “have difficulties
to concentrate on what I’m doing if the environment is
distracting”, “easily feel pressure when told to speed up
work”, “feel insecure when facing new tasks”, “think I have
less energy than most people I know” [27]. SSP-stress
susceptibility showed medium to high correlations with
scores of anxiety, depression, SSP-somatic- and -psychic
anxiety, SSP-lack of assertiveness and SSP-mistrust.
Hence, these individuals are likely to experience and
encounter more stress in their daily life compared with
less psychologically vulnerable individuals, which in turn
may increase stress- related immune dysregulation [31].
To the best of our knowledge, this study is one of the
few to thoroughly investigate psychological traits in rela-
tion to subjective stress-reactivity in patients with psor-
iasis. Some previous researchers have examined this
subject [7-9,13,14,23], however with different method-
ology and never with the SSP-scale or, to our knowledge,
with any other validated personality scale.
In a large Nordic psoriasis study by Zachariae et al.,
[8] 66% of the patients reported a subjective stress
reactivity, as compared with 63% in our study. Their
results suggested an indirect association between stress-
reactivity and psychological vulnerability, since stress
reactivity was significantly associated with more frequent
use of tranquillisers, anti-depressants and tobacco, as
compared with non-stress reactors.
In a study by O’Leary et al. [13] 61% of the sample re-
ported a strong belief in stress/psychological attributes
as a causal factor in their psoriasis. Consistent with our
results, this belief was significantly associated with
poorer levels of psychological well-being, in terms of
higher levels of anxiety, depression and also with more
perceived stress. Perceived stress was measured by a
questionnaire and may correspond to some of the ques-
tions measuring SSP-stress susceptibility this study [13].
In accordance with our study and the O’Leary study,
Fortune et al. [23] found that patients with psoriasis and
a strong belief in an emotional cause of their psoriasis
were more likely to experience pathological worry than
those who believed the cause to be physical.
Gupta et al. [9] showed that approximately 50% of 127
patients with psoriasis reported high stress-reactivity (≥7
on a 10-point scale). High stress reactors were more
likely to report difficulties with the assertion of anger.
Interestingly, in our study, traits of verbal and physical
aggressiveness were the only personality traits where SRs
showed lower mean scores than NSRs. This may indicate
that the ability to express anger is a resource in coping
with stress. Furthermore, Gupta et al. [9] found that high
stress reactors more often had a tendency to rely upon
the approval of others. This is similar to our findings of
higher scores of SSP-lack of assertiveness in patientswith stress reactivity. Submissiveness and wanting ap-
proval of others is likely to create more daily stress, since
social support and a sense of coherence are important
factors in stress management [32,33]. In a longitudinal
stydy, Kupfer and colleagues [34] found that patients
with a low sense of coherence experienced their first
psoriasis relapse 3.5 months after completion of treat-
ment, whereas patients with a high sense of coherence
experienced their first relapse after 10 months.
In a study of 50 patients with psoriasis, Devrimci-
Ozguven et al. [14] did not find any significant differences
between stress reactors and non-stress reactors regarding
psychological morbidity in terms of Beck Depression
Inventory and Spielberger state and trait anxiety scores.
Due to a relatively small sample size, their results may
be interpreted with some caution.
Patients defined as “non-stress reactors” (NSRs) in
our study reported lower scores of both state and
trait anxiety compared with a normative sample. Fur-
thermore, they showed lower scores of SSP-somatic trait
anxiety, SSP-psychic trait anxiety, SSP-stress-susceptibility,
SSP-lack of assertiveness and SSP-mistrust. NSRs thus
seem to be psychologically stable individuals, and may
probably tolerate and overcome the effects of stressors
in many situations. In clinical practice, it is always im-
portant to be attentive to psychological morbidity of the
patients; however, these results indicate that clinicians
may be less concerned about psychological morbidity in
patients who do not associate their disease with stress.
Previous researchers have found stress reactivity to be
associated with younger age, more psoriasis-related dis-
tress [9], greater disease severity and poorer disease-
related quality of life [8], compared with non-stress
reactors. However, in our study we found no significant
differences between SRs and NSRs regarding disease se-
verity, psoriasis related distress or any of the other clin-
ical or socio-demographic variables shown in Table 1.
Onset and stress
Nearly 50% of the patients in our study experienced that
onset of their psoriasis was related to a particular stress-
ful period or situation in life. Our results differ slightly
from Zachariae’s study [8], where 35% of the subjects
reported that the onset of their psoriasis occurred during
a time of worry and stress. Due to the potential risk of
retrospective recall bias, these results should be inter-
preted with caution. However, it is interesting that also
patients with an experienced association between onset
and stress reported significantly higher scores of both
depression and traits of anxiety, compared with those
without this association.
Subjective reporting and retrospective studies will
always involve some degree of scientific uncertainty re-
garding the potential influence of recall and cognitive
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the association between psychological distress and psor-
iasis, a substantial portion of the patients in this, and
previous studies [8-13], perceived psychological distress
to be a causative factor in the manifestation of their
disease. Patients with a chronic condition are likely to
construct their own personal perceptions and ideas
about their disease, in an attempt to better deal with it
[35]. The beliefs that patients have about the causes of
symptoms or diseases can have a profound effect on
clinical management, compliance with treatment and
prognosis [36]. The use of a single question for stress
reactivity would provide a simple method in clinical
practice to identify potentially psychologically vulner-
able individuals. Results from this and previous studies
[7-9,13,23] suggest important opportunities for clini-
cians to identify those patients who might benefit from
a deeper psychological exploration.
PASI scores were estimated in the latter half of our
study sample (48%), which is a limitation. However, all
patients were interviewed during the same time of year
i.e. early autumn, which might implicate relatively simi-
lar levels of disease severity in the entire sample. The
great majority (77%) of the 48 patients scored had PASI
scores representing mild disease; hence this variable was
not used in the logistic regression analysis, which may
be a limitation. However, PASI has often not been
significantly associated with psychological morbidity in
previous studies [37-39].
The methodological strengths of this study are the
high participation rate and that all patients were inter-
viewed by the same researcher. All patients were con-
secutively recruited from the same clinic, and only eight
of 109 patients declined participation. Moreover, the
total study sample showed a homogeneous personality
profile and was not more anxious or depressed than the
general population [24,25]. Thus, it may be assumed that
the patients in this study represent a psychiatrically
normal sample in further analyses of stress reactivity and
interpretation of results.
Conclusions
According to our results, patients who perceive stress as
a causal factor for exacerbation of their disease seem to
have a more vulnerable psychological constitution. This
finding suggests important opportunities for clinicians to
identify patients who might benefit from additional psy-
chological exploration and support.
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